Sun, Sep 21, 2014, 7:42 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Celgene Corp. (CELG) Message Board

  • strater_dave strater_dave Sep 5, 2013 12:38 PM Flag

    So did the Psoriais drug FAIL for some reason

    long time no news,,,,,,,,getting to be Loooong time......usualy not good, long waits...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Company filed for apremilast approval in PsA with a PDUFA date around end of Q1 2014. And I believe is filing for Psoriasis 2nd half of 2013 and for both PsA and Ps in EMA 2nd half of 2013.

      I believe another Phase 3 (Anklosing spondylitis) is expected to have an end point readout around Q1 2014 also.

      So I believe the answer to your question is 'no'. Psoriasis study did not fail. Met endpoint and filing is due sometime during remainder of 2013 for FDA and EMA approval.

      glta

      value

      Sentiment: Buy

      • 1 Reply to valueinvestor411
      • ((((filing for Psoriasis 2nd half of 2013 and for both PsA and Ps in EMA 2nd half of 2013))))))

        Thats what I mean, second half is here, has it been filed? we are half way into second half, granted we have half-way to go, but if the data is so slam-dunk good whats the hold up? To give insider information folks time to buy more cheaper? Or maybe not so good after all?

 
CELG
93.85+0.58(+0.62%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.